PRAME and non-small cell lung carcinoma: We demonstrated wide-ranging expression of PRAME mRNA and protein across melanoma subtypes, gynecologic cancers (ovarian and endometrial), lung (SCLC and NSCLC), and TNBC, consistent with previous reports [5, 35].